Stay updated on ADHD care by reviewing new treatment options and navigating the dangers of medication shortages. With patients at risk from counterfeit drugs and overdose as a result of current shortages, now is the time to arm yourself with the knowledge to advocate for and protect your patients. Don't wait—this course is essential for ensuring the safe, effective management of your patients with ADHD.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Jena Quinn, PharmD
CEO
Perfecting Peds

Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

CPE INFORMATION
 Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Recognize the impact of ADHD medication shortages on patient safety, including the risks associated with counterfeit medications.
2. Discuss emerging ADHD treatment options and their potential applications in clinical practice.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-269-H01-P
Initial release date: 10/7/2024
Expiration date: 10/7/2025
Additional CPE details can be found here.